The company’s chief executive, Musk’seuters that Synchron Inc., a rival to Elon Musk’s Neuralink brain implant startup, is preparing to recruit patients for a large-scale clinical trial that requires company commercial approval for its device.
Synchron CEO Thomas Oxley said in an interview he plans to launch an online registry for patients interested in joining the trial, which is meant to include dozens of participants. About 120 clinical trial centres have expressed interest in helping run the study.”Part of this registry is to start to enable local physicians to speak to patients with motor impairment”, he said.”There’s a lot of interest, so we don’t want it to come in a big bottleneck right before the study we’ll be doing”
New York-based Synchron is farther along in testing its brain implant than Neuralink. Both companies initially aim to help paralysed patients type on a computer using devices that interpret brain signals.
